by University of Cambridge Credit: CC0 Public Domain Scientists have made a promising step towards developing a new drug for treating acute myeloid leukaemia, a rare blood disorder. In a study published today in Nature, Cambridge researchers report a new approach to cancer treatment that targets enzymes which play a key role in translating DNA into...
by QIMR Berghofer Medical Research Institute New QIMR Berghofer research has identified how an early genetic change in blood and bone marrow cells paves the way for the development of some blood cancers. The discovery provides a new target for treatment of the blood cancers myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML). MDS is...
by Manel Esteller and Alberto Bueno-Costa, Josep Carreras Leukaemia Research Institute Researchers of the Josep Carreras Leukaemia Research Institute discover that a leukaemic cell is capable of transforming into a non-cancerous cell through epigenetic changes. All the tissues of our body have the same DNA, but they perform very different functions and have very different aspects. For example, a lymphocyte and a neuron share...
This news or article is intended for readers with certain scientific or professional knowledge in the field. Malin Lindqvist Appell is working to develop tools to tailor the treatment of leukaemia and inflammatory bowel disease. Serious adverse drug reactions can now be avoided using a blood sample to determine who can take a lower dose of a...
Procedure is administered during three or four hospital outpatient appointments It has shown particular promise for leukaemia and blood cancers A revolutionary cancer treatment that alters the body’s cells so they attack tumours has offered hope of a cure. The procedure is administered during three or four hospital outpatient appointments which last up to four...
